BIOLIGN CONFERENCE
The BIOLIGN Conference Singapore 2026 aims to provide a high-level platform for government agencies, local/multinational pharmaceutical companies, Biotech, CRO/CDMO/CMO, investment institutions, research institutes and universities, parks, intelligentization, automation, digitalization, detection/quality analysis, gene sequencing and multi-omics research, organoid/ animal models/drug sensitivity testing, instruments/equipment/reagents, cell culture/virus vectors/consumables, single-use technology, purification/separation, law firms/consulting firms and other relevant institutions to exchange ideas, refine consensus, gain insights into the frontier trends and technological innovations in the pharmaceutical industry, and jointly explore the path of collaborative innovation in the pharmaceutical biotechnology industry.
Click here for post-event highlights and live coverage of BIOLIGN Thousand-people Assembly in South China！
Download Post-event Report of South China Conference
BIOLIGN 2026@Singapore
500+
ATTENDEES
50+
SPEAKERS
100+
B2B MATCHMAKING
30+
SPONSORS
Enabling New Drugs to Reach the World Faster
Part of Previous Speakers
Daiming Fan
AcademicianThe Chinese Academy
of Sciences
Zhigang Tian
AcademicianThe Chinese Academy
of Engineering
Dawei Ma
AcademicianThe Chinese Academy
of Sciences
Hongzhou Lu
AAM FellowDean of The Third People's
Hospital of Shenzhen
Jinhui Li
General Manager ofHospital's Emergency BU
Pfizer China
Jiang Qian
GM of ChinaBMS
Zhigang Sun
VP, CQOHengrui Pharmaceuticals
Yutian Wang
AcademicianRoyal Society of
Canada
Jens Ewert
Life Sciences &Health Care Leader
Deloitte China
Tony Guo
VP and Global Head ofStatistics and Data Sceince
BeOne
Mingxiu Hu
SVPAkeso
Xueqing Yu
DeanGuangdong Provincial
People's Hospital
Kaisheng Huang
CQORemeGen Co., Ltd.
Linna Wang
CMO at Chia TaiInnovation R&D Center
China Biopharma
CMO
Dongzhou Liu
CSO & President ofGlobal Development
Huadong Medicine
Ling Yang
VPCTTQ PHARMA
Aimin Hui
General ManagerSharpSight Biopharma
Consulting
Wenzhi Tian
Chairman and GMImmuneOnco
Lun Zeng
VPXiangxue Pharmaceutical
Yongzeng Wang
CTOJuventas
Gang Qin
CEO/Founder/ChairmanGeneQuantum
Healthcare
Ruhong Jiang
CEOASC Therapeutics
Gong Chen
FounderNeuExcell
Therapeutics
Fubing Li
Co-Founder/CSOConstimulus
Wenji Dong
Founder&CEOGenmedicn Biopharma
Jiaqiang Cai
Co-founder&CSOMediLink Therapeutics
Wenjun Zhang
CEOExcelMab
Penghui Zhou
FounderFanen Biotechnology
Dan Liu
Managing PartnerChina Region
Pivotal bioVenture Partners
Bo Liu
Managing DirectorCDIB Capital
Quan Fu
PartnerEverest Venture
Jin Han
General ManagerTasly Pharmaceutical
Cheng Zhang
SVP & CSOGmax Biopharm LLC
Jiong Lan
Founder&CEOGenFleet Therapeutics
Minmin SUN
Founder & Chairman&CEO
Immunofoco
Lei Fang
VPLepu Biopharma
Zhong Liu
VPLunan Pharmaceutical
Group
Hugh Davis
COO&President ofU.S. Branch Biosion
Li Chen
Founder andCEO,CSO
Hua Medicine
Qiusong Tang
Head, Roche ChinaAccelartor
Roche
Xumu Zhang
RAE ForeignMember
Xiaoyan Kang
Executive VPof ClinicalDevelopment Center
& CMO (Oncology)
Qilu Pharmaceutical
James Yan
Chief OperatingOfficer, R&D
Zai Lab Limited
Zhenwei Miao
Chairman & FounderiMBioRay
Wei Chen
Vice President of R&DGan & Lee Pharmaceuticals
Zhenping Wu
SVPHUTCHMED
Ling Yang
FounderChairman & CEO
PersonGen
Hena Shi
VP & GM of OncologyDivision
Betta Pharmaceuticals
Yanhong Deng
deputy superintendentThe Sixth Affiliated Hospital
of Sun Yat-sen University
Shaojing Hu
Chairman&CEO3H Pharmaceuticals
Weimin Liu
Managing Director, InnovationCenter Investments
BeOne
Yun Qin
CMOTCRCure
Qingzhen Yu
Business PartnerGTJA Investment
Group
Pandy Song
PartnerNorthern Light
Venture Capital
Xuanhui Xie
Chief Innovation &Investment Officer
IASO BIO
Shuhang Wang
Assoc. Chief Physician, GCP CenterCancer Hospital Chinese Academy
of Medical Sciences
Robert Zhao
General ManagerDAC Biotech
Juncheng Wen
CMOPoly Pharma
Weide Zhong
Chief PhysicianGuangzhou First
People's Hospital
Xuejun Liang
Chairman & CEONovoCodex
Chunlai Cao
General ManagerThe United Laboratories
International Holdings Ltd
Hongyun Zhao
Deputy DirectorSun Yat-sen University
Cancer Center
Qinru Liang
CSOHEC CJ PHARM
Peng Lin
Deputy General ManagerChina Resources Biomedical
Yuanjia Hu
Director, Drug RegulationCenter
University of Macau
Jinzhong Chen
VPLuye Life Sciences
Zhongfang Wang
ResearcherGuangzhou Laboratory
Furong Li
Associate DeanSUSTech Health Institute
Yonghong Hi
Deputy General ManagerCorreGene
Hingyu Zhu
Chief Business Strategy& Development Officer
GeneQuantum
Chang Bai
Co-CEO &CSOIONOVA LIFE
Yandong Zhang
General ManagerCSO
KEYE LIFE
Qun Dang
PresidentGenuine Biotech
Tinke Tang
General ManagerBusiness Development
Livzon Pharmaceutical
Linping Wu
ResearcherGIBH
Jiasheng Xie
Executive PresidentGDMV
Jin Fan
Founder/CEOHopstem Biotechnology
Yang Hu
CEOLumiere Therapeutic
Yihan Wang
Founder, Chairman& CEO
TargetRx
Jiancun Zhang
ChairmanHenovcomBioscience
Binhe Tan
Partner & VPManufacturing & CMC
BRL Medicine
Xianfeng Lu
DeputyGeneral Manager
InnoCare
Jianxin Duan
Chairman & GeneralManager
Ascentawits
Ping Zhou
ChairmanWuhan Yinuo Pharmaceutical
Meng Yu
Deputy General ManagerChina & Executive Director
HighTide
Chenguang Yuan
Co-Founder & CSOSungening Bio-Medical
Xiaoping Chen
Founder & CSOCAS Lamvac Biotech
Shubin Wang
Director, Department of OncologyPeking University
Shenzhen Hospital
Tao Xu
Director, R&D Center,Tsinghua Shenzhen
Research Institute
Haitao Li
CTORigerna Therapeutics
Yuqiang Wang
CEOMagpie Pharmaceuticals
Hualin Chen
Chief PhysicianPulmonary Oncology
Affiliated Hospital of
GDMU
Jiayin Yang
Co-FounderCTO
Cell Inspire
Jinjing Zhang
PartnerWestGene
Su Wu
irector, InnovativeDrug Research Center
GBA-IPM
Chen Chen
CBOMicot
Job Titles Align with the Newest Information
Part of Collaborative Partners
Part of Media Partners
Industry Insights – Empowering Innovations
Spectacle of Previous Conferences
